A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
Ware, K E, Hinz, T K, Kleczko, E, Singleton, K R, Marek, L A, Helfrich, B A, Cummings, C T, Graham, D K, Astling, D, Tan, A-C, Heasley, L E
Published in Oncogenesis (New York, NY) (25.03.2013)
Published in Oncogenesis (New York, NY) (25.03.2013)
Get full text
Journal Article
MA11.01 Development of Novel EGFR Mutant NSCLC Mouse Models and Murine Cell Lines: New Tools for NSCLC Research
Kleczko, E., Le, A., Hu, C., Weiser-Evans, M., Heasley, L., Nemenoff, R.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
P53.05 Inhibition of Tumor Cell Intrinsic Complement Regulatory Proteins Leads to Decreased Tumor Growth in a Mouse Model of NSCLC
Kleczko, E., Navarroa, A., Laskowski, J., Wu, M., Johnson, A., Gottlin, E., Bushey, R., Campa, M., Patz, E., Thurman, J., Nemenoff, R.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article